Scope Biosciences Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.27M

  • Investors
  • 8

Scope Biosciences General Information

Description

Operator of a molecular diagnostics technology designed to enable accessible nucleic acid detection in healthcare and agriculture. The company's technology offers specificity in detecting single-nucleotide differences, sensitivity to trace genetic material, and a format operable outside laboratory settings, enabling healthcare providers and agricultural professionals to make on-site decisions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Bronland 12B-1
  • 6708 WH Wageningen
  • Netherlands
+31 06
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Corporate Office
  • Bronland 12B-1
  • 6708 WH Wageningen
  • Netherlands
+31 06

Scope Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Scope Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Seed Round 16-Jun-2025 $2.27M Completed Generating Revenue
7. Seed Round 24-Oct-2023 Completed Generating Revenue
6. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
5. Corporate 29-Oct-2021 Completed Generating Revenue
4. Accelerator/Incubator Completed Startup
3. Accelerator/Incubator 01-Jan-2020 Completed Startup
2. Accelerator/Incubator 01-Jan-2019 Completed Startup
1. University Spin-Out 01-Jan-2020 Completed Startup
To view Scope Biosciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Scope Biosciences Patents

Scope Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3987058-A1 Type iii crispr/cas-based diagnostics Active 19-Jun-2019
EP-3987058-B1 Type iii crispr/cas-based diagnostics Active 19-Jun-2019
EP-3987058-C0 Type iii crispr/cas-based diagnostics Active 19-Jun-2019
EP-4497833-A2 Type iii crispr/cas-based diagnostics Active 19-Jun-2019
EP-4497833-A3 Type iii crispr/cas-based diagnostics Active 19-Jun-2019 C12Q1/6823
To view Scope Biosciences’s complete patent history, request access »

Scope Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Scope Biosciences Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Oost NL Venture Capital Minority
SHIFT Invest Venture Capital Minority
StartLife Accelerator/Incubator
GenDx Corporation Minority
LifeSciences@Work Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Scope Biosciences FAQs

  • When was Scope Biosciences founded?

    Scope Biosciences was founded in 2020.

  • Where is Scope Biosciences headquartered?

    Scope Biosciences is headquartered in Wageningen, Netherlands.

  • What is the size of Scope Biosciences?

    Scope Biosciences has 12 total employees.

  • What industry is Scope Biosciences in?

    Scope Biosciences’s primary industry is Biotechnology.

  • Is Scope Biosciences a private or public company?

    Scope Biosciences is a Private company.

  • What is Scope Biosciences’s current revenue?

    The current revenue for Scope Biosciences is .

  • How much funding has Scope Biosciences raised over time?

    Scope Biosciences has raised $3.96M.

  • Who are Scope Biosciences’s investors?

    Oost NL, SHIFT Invest, StartLife, GenDx, and LifeSciences@Work are 5 of 8 investors who have invested in Scope Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process